Johnson and Johnson Pharmaceutical Development, Turnhoutseweg 30, B-2340 Beerse, Belgium. slemaire@its.jnj.com
Abstract:
Diastereoselective hydrogenation of 2'-deoxy-2'-exo-methyleneuridine was carried out under homogeneous conditions using a low loading of a chiral Rh catalyst. This, coupled with improvements in the synthesis of the substrate, allowed the smooth pilot plant preparation of the title compound on >10 kg scale.